Cullinan Oncology, Inc. (CGEM) Financials
CGEM Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 485.1 million | 31.2 million |
2023-09-30 | 494.7 million | 25.9 million |
2023-06-30 | 522.0 million | 22.4 million |
2023-03-31 | 515.0 million | 29.3 million |
CGEM Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -18.1 million | 7.5 million |
2023-09-30 | -34.1 million | 7.7 million |
2023-06-30 | -31.1 million | 7.9 million |
2023-03-31 | -51.2 million | 7.3 million |
CGEM Net Income
No data available :(
CGEM Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 467.1 million | - | 3.6 million |
2023-09-30 | 466.4 million | - | 4.0 million |
2023-06-30 | 512.1 million | - | 4.4 million |
2023-03-31 | 390.7 million | - | 4.7 million |
CGEM Shares Outstanding
CGEM Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 34.8 million | 10.6 million | 77000 |
2023-09-30 | - | 33.8 million | 11.0 million | - |
2023-06-30 | 49000 | 27.4 million | 10.2 million | - |
2023-03-31 | 159000 | 52.1 million | 10.7 million | - |
CGEM Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 77000 |
2023-09-30 | - | 80000 |
2023-06-30 | - | 81000 |
2023-03-31 | - | 72000 |
CGEM
Price: $27.58
52 week price:
Earnings Per Share: -3.69 USD
P/E Ratio: -4.79
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 351200
Market Capitalization: 733.0 million